Search results
Showing 1966 to 1980 of 9102 results
Alectinib for treating unresectable locally advanced non-small-cell lung cancer [GID-TA12468]
Awaiting development Reference number: GID-TA12468 Expected publication date: TBC
Awaiting development Reference number: GID-HTG10173 Expected publication date: TBC
Tideglusib for treating congenital or childhood onset myotonic dystrophy [ID3915]
Awaiting development Reference number: GID-TA10791 Expected publication date: TBC
Maralixibat for treating cholestatic pruritus in Alagille syndrome [ID3941]
In development Reference number: GID-TA10832 Expected publication date: TBC
Itopride hydrochloride for treating gastrointestinal symptoms of functional dyspepsia [ID6745]
Awaiting development Reference number: GID-TA11979 Expected publication date: TBC
Awaiting development Reference number: GID-TA10833 Expected publication date: TBC
Nipocalimab for treating generalised myasthenia gravis [ID6562]
Awaiting development Reference number: GID-TA11492 Expected publication date: TBC
Inebilizumab for treating generalised myasthenia gravis [ID6587] [TSID12110]
Awaiting development Reference number: GID-TA11667 Expected publication date: TBC
Pozelimab with cemdisiran for treating symptomatic generalised myasthenia gravis [ID6720]
Awaiting development Reference number: GID-TA11874 Expected publication date: TBC
In development Reference number: GID-TA11958 Expected publication date: 21 April 2027
Clone of IPG190 Insertion of pleuro–amniotic shunt for fetal pleural effusion
HealthTech guidance Reference number: HTG123 Published: 27 September 2006
Ibrutinib for treating relapsed or refractory follicular lymphoma [ID1251]
In development Reference number: GID-TA10223 Expected publication date: TBC
Talacotuzumab for untreated acute myeloid leukaemia [ID1262]
In development Reference number: GID-TA10249 Expected publication date: TBC
STG320 for treating allergic rhinitis or rhinoconjunctivitis caused by house dust mites [ID1278]
Awaiting development Reference number: GID-TA10279 Expected publication date: TBC
Awaiting development Reference number: GID-TA10748 Expected publication date: TBC